What is macular degeneration?
Macular degeneration (MD) is primarily an age-related retinal condition which affects central vision. This means that people with macular degeneration can’t see things directly in front of them. This common age-related eye condition which mostly occurs in people over the age of 50. There are two types of macular degeneration — wet and dry. It affects one or both eyes with different levels of severity.
How common is MD?
Almost 20 million U.S. adults have macular degeneration. In the U.S., macular degeneration is a leading cause of vision loss in people who are 60 and older.
What are the risk factors for MD?
Some people can develop macular degeneration at younger ages because of several factors. Risk factors for getting MD are:
What are the types of MD?
There are 2 main types of MD:
What are the causes of MD?
No one knows exactly what causes dry macular degeneration. Research suggests that it may be a combination of genes and other factors, including smoking, obesity and diet.
The condition develops as the eye ages. Dry macular degeneration affects the macula. The macula is the area of the retina that's responsible for clear vision in the direct line of sight. Over time, tissue in the macula may thin and lose cells responsible for vision.
What are the symptoms of MD?
Early dry MD doesn`t usually cause symptoms. As condition progresses, person may notice:
How is MD diagnosed?
In addition to a complete medical history and eye exam, your eye doctor may do the following tests to diagnose age-related macular degeneration:
Fluorescein angiography: Used to detect wet age-related macular degeneration, this diagnostic test involves a special dye injected into a vein in the arm. Pictures are then taken as the dye passes through the blood vessels in the retina, helping the doctor evaluate if the blood vessels are leaking and whether or not the leaking can be treated.
How is MD treated?
Currently, there is no cure for MD. However, supplements such as Vitamin C, E, Lutein, Zinc, Copper and Zeaxanthin can help slow down disease progression. Low-vision devices can be used to build visual skills, develop new ways to perform daily living activities and adjust to living with age-related macular degeneration.
Anti-vascular endothelial growth factor (VEGF) injections remain the mainstay to treat wet MD. They block the production of VEGF, which is a protein that produces new blood vessels. E.g. Aflibercept (Eylea®), Ranibizumab (Lucentis®), Bevacizumab (Avastin®), Faricimab-svoa (VABYSMO®). (https://my.clevelandclinic.org/health/diseases/15246-macular-degeneration)